NCT03784716 is a NA clinical trial of Ketogenic Diet in Fatty Liver, Nonalcoholic, sponsored by Marc Goodman.

Who is sponsoring NCT03784716?

NCT03784716 is sponsored by Marc Goodman.

What drugs are being tested in NCT03784716?

Interventions in NCT03784716: Ketogenic Diet, Standard Weight Loss Diet.

What condition does NCT03784716 study?

NCT03784716 studies Fatty Liver, Nonalcoholic, Liver Diseases.

Is NCT03784716 still recruiting?

NCT03784716 is currently completed. Last updated 11 May 2022.

Last reviewed 2022-05-11 · How we verify

NCT03784716

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Ketogenic Diet in Non-alcoholic Fatty Liver Disease

Completed NA Last updated 11 May 2022

What this trial tests

NA trial testing Ketogenic Diet in Fatty Liver, Nonalcoholic in 24 participants. Completed in 10 February 2022.

Timeline

13 March 2019

Primary endpoint
10 February 2022

10 February 2022

Quick facts

Lead sponsor	Marc Goodman
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	treatment
Enrollment	24
Start date	13 March 2019
Primary completion	10 February 2022
Estimated completion	10 February 2022
Sites	1 location across United States

Drugs / interventions tested

Ketogenic Diet — full drug profile →
Standard Weight Loss Diet

Conditions studied

Fatty Liver, Nonalcoholic — all drugs for Fatty Liver, Nonalcoholic →
Liver Diseases — all drugs for Liver Diseases →

Sponsor

Marc Goodman — full company profile →

Who can join

18 and older, any sex, with Fatty Liver, Nonalcoholic or Liver Diseases. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this randomized trial is to examine the effects of a ketogenic diet on non-alcoholic fatty liver disease (NAFLD). Twenty-four participants with NAFLD will be randomized to receive a ketogenic meal plan or control (standard weight loss meal plan). Participants will be followed up to 28 days after initiation of the diet intervention.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

The Role of the Gut Microbiota on the Beneficial Effects of Ketogenic Diets.
Attaye I, van Oppenraaij S, Warmbrunn MV, Nieuwdorp M. · · 2021 · cited 52× · PMID 35011071 · DOI 10.3390/nu14010191
Ketone body metabolism and cardiometabolic implications for cognitive health.
Fulghum K, Salathe SF, Davis X, Thyfault JP, et al · · 2024 · cited 11× · PMID 40093558 · DOI 10.1038/s44324-024-00029-y

Verify or expand the search:

Other trials of Ketogenic Diet

Trials testing the same drug.

NCT07121894 — Ketogenic Intervention for Bipolar Depression · NA · recruiting
NCT06894004 — Mechanism of Ketogenic Diet-Induced Hypercholesterolemia · NA · recruiting
NCT06515912 — Ketogenic Diet in Healthy Adults With Differing BMI · NA · completed
NCT06503809 — Efficacy and Safety of a Ketogenic Diet in Type 1 Diabetes · NA · recruiting
NCT06325644 — Well-Formulated Ketogenic Diet Polycystic Kidney Disease · NA · recruiting

Other recruiting trials for Fatty Liver, Nonalcoholic

Currently open trials in the same condition.

NCT06596109 — Lifestyle Changes in Fatty Liver; Additive Effect of Honey Intake · NA · recruiting
NCT06503120 — Nutritional Education Program for Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) · NA · active not recruiting
NCT06321211 — Development of a Novel Asian Mediterranean Diet and Its Acceptability in NAFLD · active not recruiting
NCT06445361 — Prevalence of NAFLD in T1DM Patients · NA · recruiting
NCT05855239 — Quantification of Hepatic Steatosis With Different Ultrasound Frequency · active not recruiting

Other Marc Goodman trials

Trials by the same sponsor.

NCT04457089 — Statin Therapy to Reduce Progression in Women With Platinum Sensitive Ovarian Cancer · EARLY_PHASE1 · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03784716 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Marc Goodman
Last refreshed: 11 May 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03784716.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing